Technology Offerings

New Target Antigen for pANCA Diagnostics Identified

Scientists at the University of Bonn, Germany, have identified the main target antigen for the atypical antineutrophil

cytoplasmic antibodies pANCA in autoimmune liver disorders and chronic inflammatory bowel diseases. BT-50 can be produced by recombinant means and used for the quantification of atypical pANCA in serum probes.

Further Information: PDF

PROvendis GmbH
Phone: +49 (0)208/94105 0

Contact
Dipl.-Ing. Alfred Schillert

Comments (0)

Write a comment